Literature DB >> 20679156

Prevalence of attention deficit hyperactivity disorder and associated features among children in France.

Michel Lecendreux1, Eric Konofal, Stephen V Faraone.   

Abstract

BACKGROUND: Earlier studies point to the prevalence of attention deficit hyperactivity disorder (ADHD) to be similar around the world. There is, however, a wide variety in estimates. The prevalence of ADHD in youth has never been examined in France.
METHOD: Starting with 18 million telephone numbers, 7,912 numbers are randomly selected. Among the 4,186 eligible families, 1,012 (24.2%) are successfully recruited. A telephone interview is administered to all families about a child in the 6 to 12 age range. It covered family living situation, school performance, symptoms of ADHD, conduct disorder (CD), and oppositional-defiant disorder (ODD), and other features of ADHD.
RESULTS: The prevalence of ADHD in France is between 3.5% and 5.6%. The population prevalence of treatment for ADHD is 3.5%. ADHD youth are more likely to be men than women, and, compared to non-ADHD children, ADHD children are more likely to have CD and ODD. Having ADHD is associated with a family history of the disorder. The ADHD youth are more likely to have had learning difficulties, to have repeated a grade, and to be functioning academically below grade level.
CONCLUSIONS: The epidemiology of ADHD in French children is similar to the epidemiology of ADHD in other countries. The disorder occurs in between 3.5% to 5.6% of youth and is more common among boys than among girls. The authors replicate the well-known association of ADHD with CD, ODD, and indices of school failure. The impact of ADHD symptoms on school performance highlights the importance of screening for such symptoms in schools.

Entities:  

Mesh:

Year:  2010        PMID: 20679156     DOI: 10.1177/1087054710372491

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  19 in total

1.  Potential contribution of monoamine oxidase a gene variants in ADHD and behavioral co-morbidities: scenario in eastern Indian probands.

Authors:  A Karmakar; S Maitra; D Verma; B Chakraborti; R Goswami; P Ghosh; S Sinha; K P Mohanakumar; R Usha; K Mukhopadhyay
Journal:  Neurochem Res       Date:  2014-03-21       Impact factor: 3.996

2.  ADHD modulates the course of delinquency: a 15-year follow-up study of young incarcerated man.

Authors:  Florence Philipp-Wiegmann; Michael Rösler; Oriana Clasen; Toivo Zinnow; Petra Retz-Junginger; Wolfgang Retz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-06-13       Impact factor: 5.270

3.  Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers.

Authors:  Akwete Adjei; Robert J Kupper; Nathan S Teuscher; Sharon Wigal; Floyd Sallee; Ann Childress; Scott H Kollins; Laurence Greenhill
Journal:  Clin Drug Investig       Date:  2014-11       Impact factor: 2.859

4.  Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms in Pediatric Narcolepsy: A Cross-Sectional Study.

Authors:  Michel Lecendreux; Sophie Lavault; Régis Lopez; Clara Odilia Inocente; Eric Konofal; Samuele Cortese; Patricia Franco; Isabelle Arnulf; Yves Dauvilliers
Journal:  Sleep       Date:  2015-08-01       Impact factor: 5.849

5.  Mild head injury and attention deficit hyperactivity disorder in children.

Authors:  Veronique Chasle; Laurent Riffaud; Romain Longuet; Marie Martineau-Curt; Yann Collet; Luc Le Fournier; Patrick Pladys
Journal:  Childs Nerv Syst       Date:  2016-08-27       Impact factor: 1.475

6.  Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015.

Authors:  Christel Renoux; Ju-Young Shin; Sophie Dell'Aniello; Emma Fergusson; Samy Suissa
Journal:  Br J Clin Pharmacol       Date:  2016-06-09       Impact factor: 4.335

7.  Prescription drug dispensing profiles for one million children: a population-based analysis.

Authors:  Tingting Zhang; M Anne Smith; Pat G Camp; Salomah Shajari; Stuart M MacLeod; Bruce C Carleton
Journal:  Eur J Clin Pharmacol       Date:  2012-07-12       Impact factor: 2.953

8.  Prevalence and Risk Factors Associated With Attention-Deficit/Hyperactivity Disorder Among US Black Individuals: A Systematic Review and Meta-analysis.

Authors:  Jude Mary Cénat; Camille Blais-Rochette; Catherine Morse; Marie-Pier Vandette; Pari-Gole Noorishad; Cary Kogan; Assumpta Ndengeyingoma; Patrick R Labelle
Journal:  JAMA Psychiatry       Date:  2021-01-01       Impact factor: 21.596

9.  A systematic review of global publication trends regarding long-term outcomes of ADHD.

Authors:  Paul Hodgkins; L Eugene Arnold; Monica Shaw; Hervé Caci; Jennifer Kahle; Alisa G Woods; Susan Young
Journal:  Front Psychiatry       Date:  2012-01-18       Impact factor: 4.157

10.  Relationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit/hyperactivity disorder: a physician perspective.

Authors:  Juliana Setyawan; Moshe Fridman; Paul Hodgkins; Javier Quintero; M Haim Erder; Božena J Katić; Valerie Harpin
Journal:  Atten Defic Hyperact Disord       Date:  2014-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.